“life-sciences” Archives

in
Entry Author Date Location
Biotech Beware, Your Culture is Showing 06/15/18 Boston
Teva’s Migraine Drug Fails in Phase 3 for Chronic Cluster Headaches 06/15/18 National
Metabolon CEO John Ryals Retires, Rohan Hastie Named Successor 06/15/18 Raleigh Durham
Northern Biologics’ Rahul Ballal Joins Imara as CEO 06/15/18 Boston
Bio Roundup: Not-BIO Party Foul, CRISPR Drama, Sickle Cell Updates 06/15/18 National
For Sickle Cell, a Complex Disease, New Drugs Could Bring Complex Costs 06/15/18 San Francisco
Bluebird’s Upgraded Gene Therapy Shows Promise For Sickle Cell Patients 06/15/18 Boston
Benchling Scores $14.5M to Grow Online Lab Notebook for Bio-Researchers 06/14/18 San Francisco
Mindstrong Adds $15M for Tech That Predicts Mental Health Changes 06/14/18 San Francisco
Jayson Dallas Leaves Ultragenyx for CEO Post at Aimmune 06/13/18 San Francisco
Biogen’s Gilmore O’Neill Joins Sarepta as Chief Medical Officer 06/13/18 Boston
Take Two: Biotech Party with Nearly Nude Women Condemned by Industry Leaders 06/13/18 Boston
NIH Outlines $500M Plan to Develop New Pain Drugs and Fight Opioid Crisis 06/13/18 National
Westphal’s Flex Pharma To Cut Jobs and Seek Sale After Clinical Flop 06/13/18 Boston
Last Chance to Save on June 21’s ‘New York Biotech: Bringing Back the Expats’ 06/13/18 National
16 Tech’s 60-Acre Innovation Community Coming Soon to Downtown Indy 06/13/18 Indiana
No Price Cuts Yet, But Azar Urges Congress to Target Drug Rebates & Transparency 06/12/18 National
Zurex Pharma Raises $9M to Fight Hospital-Acquired Infections 06/12/18 Wisconsin
Sage Speeds Ahead With Plans For a Short-Course Depression Drug 06/12/18 Boston
In Digital Device Boom, Tear Film Sees Window for Dry Eye Treatment 06/12/18 San Diego
Allergan’s Migraine-Reducing Pill Hits Study Goals, Heads to Phase 3 06/11/18 New York
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells 06/11/18 National
Halozyme, Edico CEOs Among San Diego’s Entrepreneurs of the Year 06/11/18 San Diego
Triumvira Immunologics Names Donna Rill Chief Technology Officer 06/11/18 Texas
TraceLink Tracks Down $60M to Fight Counterfeit Drugs Worldwide 06/11/18 Boston
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines 06/11/18 Boston
Exact Sciences Seeks Up to $190M in Latest Stock Offering 06/08/18 Wisconsin
Bio Roundup: Wrapping ASCO, Dreaming IPO, Rebooting Axovant & More 06/08/18 National
Alder BioPharmaceuticals Picks Juno’s Robert Azelby for CEO 06/07/18 Seattle
Novartis’ Hinshaw Joins Axcella Health as President & CEO 06/07/18 Boston
Page 1 of 359 next page »